With deep influences from the French and Iranian New Waves, Universal Language is equal parts a moving experience and a ...

Labomatic Instruments and Knauer recently announced a new strategic cooperative relationship to offer their instrument portfolios to each other’s customer bases.

AZtecGeo is a geoscience-dedicated user profile for particle analysis software AZtecFeature, designed to guide the automated ...

The new benchtop encloser can be equipped with interchangeable onboard air filtration options to protect samples from ...

The first patient has been dosed in a phase 1 dose-finding clinical trial evaluating iadademstat with Vidaza in patients with ...

The Food and Drug Administration (FDA) has approved Grafapex ™ (treosulfan) for injection with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell transplantation (alloHSCT) in ...

The Spring Festival Golden Week will begin next Tuesday (28 February) for a stretch of eight days (28 January – 4 February). Macao Government Tourism Office (MGTO) has been carrying out a variety of ...

Opens in a new tab or window The FDA approved treosulfan (Grafapex) with fludarabine as a preparative regimen for allogeneic hematopoietic stem cell transplantation in patients ages 1 year and ...

The following is a message from FDA: On January 21, 2025, the Food and Drug Administration approved treosulfan (Grafapex, medac GmbH), an alkylating agent, with fludarabine as a preparative regimen ...

Advanced Membranes and Porous Materials Center, Physical Science and Engineering Division, King Abdullah University of Science and Technology (KAUST), Thuwal 23955-6900, Saudi Arabia Center for ...

The FDA has approved the investigational new drug application of 225Ac-SSO110, allowing for the start of a phase 1/2 trial in patients with extensive-stage small cell lung cancer and Merkel cell ...

The FDA granted priority review to datopotamab deruxtecan in advanced EGFR-mutated NSCLC after prior therapies, with a decision expected by July 12, 2025. The FDA has accepted and granted priority ...